Taaleritehdas Plc has completed an IPO on NASDAQ First North Finland and raised US$18 million
Taaleritehdas Plc has completed an IPO on NASDAQ First North Finland and raised US$18 million.
Taaleritehdas is a group listed on the First North Finland marketplace on the Helsinki Stock Exchange maintained by NASDAQ OMX Helsinki. Taaleritehdas offers wealth management and financing services to institutional investors, companies and private individuals. On 30 June 2015, Taaleritehdas had assets under management of approximately US$4 billion and 3,300 wealth management clients. Taaleritehdas has been awarded the second best IPO in Europe in a prominent European competition that honors the best IPOs by small and mid-cap companies.
Oaklins' team in Finland acted as exclusive advisor in the IPO of Taaleritehdas Plc on Nasdaq OMX First North Finland. The B-class shares of Taaleritehdas started trading on the exchange on 24 April 2013. The Finnish team also acted as the Certified Advisor to Taaleritehdas.


Talk to the deal team
Related deals
Hemink Groep has been acquired by Gimv
Gimv has acquired a majority stake in Hemink, a Dutch specialist in real estate renovation and maintenance. This transaction marks a new chapter for Hemink, as it seeks to expand its position as a national leader in sustainable property services through its new partnership with Gimv.
Learn moreOGD has been sold to Building Beyond Technology Group
Building Beyond Technology Group (BBTG) strengthens its position in the IT sector by welcoming OGD IT-Dienstverlening (OGD) to its platform. With over 1,400 employees, OGD is an established name in the Dutch market as a mission-critical IT service provider for large-scale clients. This addition not only increases BBTG’s scale but also enhances its domain expertise and execution capabilities through close cooperation with the other platform companies.
Learn moreThe Providence Projects has been acquired by UKAT Group
Celebrity-success rehabilitation center, The Providence Projects, has joined The UK Addiction Treatment (UKAT) Group, backed by Sullivan Street Equity Partners.
Learn more